MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HACKNEY, J. F.
Right arrow Articles by PRATT, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HACKNEY, J. F.
Right arrow Articles by PRATT, W. B.

Molecular Pharmacology, Vol 6, 500-512, Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics

Specific Glucocorticoid-Binding Macromolecules from Mouse Fibroblasts Growing in Vitro

A Possible Steroid Receptor for Growth Inhibition

JOHN F. HACKNEY 1, STEPHEN R. GROSS 1, LEWIS ARONOW 1, and WILLIAM B. PRATT 1

1 Department of Pharmacology, Stanford University School of Medicine, Stanford, California 94305

Mouse fibroblasts growing in vitro (L cells) contain a binding component for triamcinolone acetonide which is apparently distributed intracellularly, largely as a cytoplasmic soluble macromolecule. The structure-activity relationships of steroids active in growth inhibition are exactly paralleled by their ability to displace 3H-triamcinolone acetonide from this binding component. The binding component is saturated between 10-8 and 5 x 10-8 M triamcinolone acetonide. The macromolecules bind unchanged triamcinolone acetonide noncovalently, and the steroid is released from binding by brief digestion with a proteolytic enzyme. Cells which are resistant to glucocorticoids bind much less triamcinolone acetonide in a specific manner (i.e., displaceable by glucocorticoids) than do sensitive cells. The binding component therefore satisfies many of the rigorous criteria necessary for assignment as a "receptor" for the growth-inhibitory action of glucocorticoids on mouse fibroblasts. In addition, triamcinolone acetonide bound to the 105,000 x g supernatant fraction remains bound under conditions of frozen storage for at least 1 month.

Submitted on March 27, 1970




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
P. Wei, N. Inamdar, and W. V. Vedeckis
Transrepression of c-jun Gene Expression by the Glucocorticoid Receptor Requires Both AP-1 Sites in the c-jun Promoter
Mol. Endocrinol., September 1, 1998; 12(9): 1322 - 1333.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
W. B. Pratt and D. O. Toft
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones
Endocr. Rev., June 1, 1997; 18(3): 306 - 360.
[Abstract] [Full Text]

Home page
 DevelopmentHome page
B. Barres, M. Lazar, and M. Raff
A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development
Development, January 5, 1994; 120(5): 1097 - 1108.
[Abstract] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
W. P. Parks, E. M. Scolnick, and J. C. Ransom
Glucocorticoid Induction of Murine Mammary Tumor Virus In Vitro
Cold Spring Harb Symp Quant Biol, January 1, 1974; 39(0): 1151 - 1158.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics